Dosing regimes for the treatment of ocular vascular disease

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

Brigell, Mitchell,End, Peter,Hosagrahara, Vinayak,Jaffee, Bruce,Meredith, Erik,Newton, Ronald,Poor, Stephen,Qiu, Yubin

申请号：

AU2011322597

公开号：

AU2011322597A1

申请日:

2011.10.25

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The use of vascular endothelial growth factor receptor 2 inhibitors or a pharmaceutically acceptable salt thereof for the treatment of ocular vascular disease is provided. Dosing regimes, including once weekly administration, of certain VEGF-R2 inhibitors are provided which deliver therapeutically effective concentrations of the VEGF-R2 compounds in ocular tissues for at least one week for the treatment of ocular vascular disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/